Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Scorpius Holdings Inc SCPX

Healthcare Biotechnology
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio... see more

Recent & Breaking News (NYSEAM:SCPX)

Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University

GlobeNewswire March 19, 2024

Scorpius Holdings Accepted as a Member of the US Government's BioMaP-Consortium

GlobeNewswire March 14, 2024

Scorpius Holdings, Inc. Announces Closing of Public Offering

GlobeNewswire March 12, 2024

Scorpius Holdings, Inc. Announces Pricing of Public Offering

GlobeNewswire March 8, 2024

Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire March 7, 2024

Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023

GlobeNewswire March 7, 2024

NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under "SCPX" Effective at the Market Open Today

GlobeNewswire February 6, 2024

NightHawk's Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer

GlobeNewswire February 1, 2024

NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note

GlobeNewswire January 30, 2024

NightHawk's Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program

GlobeNewswire January 25, 2024

NightHawk's Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client

GlobeNewswire January 16, 2024

NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO

GlobeNewswire January 8, 2024

NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National University

GlobeNewswire January 3, 2024

NightHawk Biosciences Announces Completion of Demonstration Run for a Top-Tier NIH and DTRA Funded Research University

GlobeNewswire December 21, 2023

NightHawk Biosciences Announces Major Milestone with Completion of Manufacturing Run for a Premier U.S.-Based Biopharmaceutical Company

GlobeNewswire December 18, 2023

NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets

GlobeNewswire December 12, 2023

NightHawk Biosciences Provides Q3 2023 Business Update

GlobeNewswire November 20, 2023

NightHawk Biosciences Provides Q2 2023 Business Update

GlobeNewswire August 14, 2023

NightHawk Biosciences Provides Q1 2023 Business Update

GlobeNewswire May 15, 2023

NightHawk Biosciences Provides 2022 Year End Business Update

GlobeNewswire March 31, 2023